This study tests a fixed-dose combination pill containing Pitavastatin and Ezetimibe against Pitavastatin alone in 88 people with high cholesterol and high triglycerides. Participants take the pill daily for 52 weeks. The main goal is to see how much LDL ('bad') cholesterol drops…
Phase: PHASE4 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC